337 related articles for article (PubMed ID: 31677901)
1. Hypofractionated stereotactic radiotherapy for challenging brain metastases using 36 Gy in six fractions.
Dumont Lecomte D; Lequesne J; Geffrelot J; Lesueur P; Barraux V; Loiseau C; Lacroix J; Leconte A; Émery É; Thariat J; Stefan D
Cancer Radiother; 2019 Dec; 23(8):860-866. PubMed ID: 31677901
[TBL] [Abstract][Full Text] [Related]
2. Impact of 2-staged stereotactic radiosurgery for treatment of brain metastases ≥ 2 cm.
Angelov L; Mohammadi AM; Bennett EE; Abbassy M; Elson P; Chao ST; Montgomery JS; Habboub G; Vogelbaum MA; Suh JH; Murphy ES; Ahluwalia MS; Nagel SJ; Barnett GH
J Neurosurg; 2018 Aug; 129(2):366-382. PubMed ID: 28937324
[TBL] [Abstract][Full Text] [Related]
3. Radiosurgery or hypofractionated stereotactic radiotherapy for brain metastases from radioresistant primaries (melanoma and renal cancer).
Lesueur P; Lequesne J; Barraux V; Kao W; Geffrelot J; Grellard JM; Habrand JL; Emery E; Marie B; Thariat J; Stefan D
Radiat Oncol; 2018 Jul; 13(1):138. PubMed ID: 30055640
[TBL] [Abstract][Full Text] [Related]
4. Stereotactic radiotherapy for large solitary brain metastases.
Feuvret L; Vinchon S; Martin V; Lamproglou I; Halley A; Calugaru V; Chea M; Valéry CA; Simon JM; Mazeron JJ
Cancer Radiother; 2014 Mar; 18(2):97-106. PubMed ID: 24439342
[TBL] [Abstract][Full Text] [Related]
5. Efficacy and safety of hypofractionated stereotactic radiotherapy for brain metastases using three fractions: A single-centre retrospective study.
Vigneau E; Jacquemin J; Benadon B; Dat Nguyen T; Marchand-Créty C
Cancer Radiother; 2021 Dec; 25(8):763-770. PubMed ID: 34083125
[TBL] [Abstract][Full Text] [Related]
6. [Hypofractionated stereotactic radiotherapy for brain metastasis: Benefit of additional whole brain radiotherapy?].
Royer P; Salleron J; Vogin G; Taillandier L; Clément-Duchêne C; Klein O; Faivre JC; Peiffert D; Bernier V
Cancer Radiother; 2017 Dec; 21(8):731-740. PubMed ID: 28711413
[TBL] [Abstract][Full Text] [Related]
7. Brain metastases treated with radiosurgery or hypofractionated stereotactic radiotherapy: outcomes and predictors of survival.
Sallabanda M; García-Berrocal MI; Romero J; García-Jarabo V; Expósito MJ; Rincón DF; Zapata I; Magallón MR
Clin Transl Oncol; 2020 Oct; 22(10):1809-1817. PubMed ID: 32124243
[TBL] [Abstract][Full Text] [Related]
8. [Hypofractionated stereotactic radiotherapy for brain metastases].
Schlienger M; Nataf F; Huguet F; Pene F; Foulquier JN; Orthuon A; Roux FX; Touboul E
Cancer Radiother; 2010 Apr; 14(2):119-27. PubMed ID: 20004125
[TBL] [Abstract][Full Text] [Related]
9. Image-Guided, Linac-Based, Surgical Cavity-Hypofractionated Stereotactic Radiotherapy in 5 Daily Fractions for Brain Metastases.
Soliman H; Myrehaug S; Tseng CL; Ruschin M; Hashmi A; Mainprize T; Spears J; Das S; Yang V; da Costa L; Maralani P; Heyn C; Atenafu EG; Sahgal A
Neurosurgery; 2019 Nov; 85(5):E860-E869. PubMed ID: 31173150
[TBL] [Abstract][Full Text] [Related]
10. Single-fraction radiosurgery versus fractionated stereotactic radiotherapy in patients with brain metastases: a comparative study.
Loo M; Pin Y; Thierry A; Clavier JB
Clin Exp Metastasis; 2020 Jun; 37(3):425-434. PubMed ID: 32185576
[TBL] [Abstract][Full Text] [Related]
11. Stereotactic radiation therapy of brain metastases from colorectal cancer: A single institution cohort.
Paix A; Antoni D; Adeduntan R; Noël G
Cancer Radiother; 2017 May; 21(3):199-204. PubMed ID: 28499660
[TBL] [Abstract][Full Text] [Related]
12. Cyberknife
Telentschak S; Ruess D; Grau S; Goldbrunner R; von Spreckelsen N; Jablonska K; Treuer H; Kocher M; Ruge M
J Cancer Res Clin Oncol; 2021 Sep; 147(9):2765-2773. PubMed ID: 33638006
[TBL] [Abstract][Full Text] [Related]
13. [Risk of radionecrosis after hypofractionated stereotactic radiotherapy targeting the postoperative resection cavity of brain metastases].
Keller A; Doré M; Antoni D; Menoux I; Thillays F; Clavier JB; Delpon G; Jarnet D; Bourrier C; Lefebvre F; Chibbaro S; Darié I; Proust F; Noël G
Cancer Radiother; 2017 Aug; 21(5):377-388. PubMed ID: 28551018
[TBL] [Abstract][Full Text] [Related]
14. Postoperative hypofractionated stereotactic brain radiation (HSRT) for resected brain metastases: improved local control with higher BED
Kumar AMS; Miller J; Hoffer SA; Mansur DB; Coffey M; Lo SS; Sloan AE; Machtay M
J Neurooncol; 2018 Sep; 139(2):449-454. PubMed ID: 29749569
[TBL] [Abstract][Full Text] [Related]
15. CyberKnife Stereotactic Radiosurgery and Hypofractionated Stereotactic Radiotherapy As First-line Treatments for Imaging-diagnosed Intracranial Meningiomas.
Manabe Y; Murai T; Ogino H; Tamura T; Iwabuchi M; Mori Y; Iwata H; Suzuki H; Shibamoto Y
Neurol Med Chir (Tokyo); 2017 Dec; 57(12):627-633. PubMed ID: 29021413
[TBL] [Abstract][Full Text] [Related]
16. Hypofractionated Stereotactic Radiosurgery and Radiotherapy to Large Resection Cavity of Metastatic Brain Tumors.
Lima LC; Sharim J; Levin-Epstein R; Tenn S; Teles AR; Kaprealian T; Pouratian N
World Neurosurg; 2017 Jan; 97():571-579. PubMed ID: 27777153
[TBL] [Abstract][Full Text] [Related]
17. Hypofractionated stereotactic radiotherapy for large brain metastases: Optimizing the dosimetric parameters.
Brun L; Dupic G; Chassin V; Chautard E; Moreau J; Dedieu V; Khalil T; Verrelle P; Lapeyre M; Biau J
Cancer Radiother; 2021 Feb; 25(1):1-7. PubMed ID: 33257109
[TBL] [Abstract][Full Text] [Related]
18. Brain metastases treated with hypofractionated stereotactic radiotherapy: 8 years experience after Cyberknife installation.
Mengue L; Bertaut A; Ngo Mbus L; Doré M; Ayadi M; Clément-Colmou K; Claude L; Carrie C; Laude C; Tanguy R; Blanc J; Sunyach MP
Radiat Oncol; 2020 Apr; 15(1):82. PubMed ID: 32303236
[TBL] [Abstract][Full Text] [Related]
19. Single-dose versus fractionated stereotactic radiotherapy for brain metastases.
Kim YJ; Cho KH; Kim JY; Lim YK; Min HS; Lee SH; Kim HJ; Gwak HS; Yoo H; Lee SH
Int J Radiat Oncol Biol Phys; 2011 Oct; 81(2):483-9. PubMed ID: 20800386
[TBL] [Abstract][Full Text] [Related]
20. Single-fraction versus hypofractionated stereotactic radiosurgery for medium-sized brain metastases of 2.5 to 3 cm.
Chon H; Yoon K; Lee D; Kwon DH; Cho YH
J Neurooncol; 2019 Oct; 145(1):49-56. PubMed ID: 31420793
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]